Valencia, CA, July 17, 2003 - Advanced Bionics announces that the HiResolution' Sound (HiRes') processing strategy, an innovation in sound processing for the new HiResolution' Bionic Ear System, is approved by the U.S. Food and Drug Administration (FDA) and Health Canada. It is now being released commercially in North America.
HiRes is a new advance in how sound is processed and delivered to the hearing nerve and is designed for improved music appreciation, better understanding in noise and greater sound clarity. Clinical trial results demonstrate that 96% of study participants preferred HiRes over conventional sound processing strategies (SAS, MPS or CIS). \
The following white papers provide more detailed performance results with HiRes:
- "Converting Patients from Conventional Strategies to HiResolution' Sound Processing", June 2003 - a report on initial experiences in switching patients from conventional strategies to HiRes sound processing.
- "A Preliminary Comparison of Performance between Patients Fit with the CII Bionic Ear and Patients Fit with the Nucleus 3G System", Dorman M.F., Spahr, A. (Arizona State University) and Kirk, K., (Indiana University School of Medicine), June 2003 - an independent study comparing performance between devices that is supported by all cochlear implant manufacturers.
HiResolution Sound requires extremely fast and efficient processing electronics, and is therefore only compatible with the CII Bionic Ear electronic platform.
Advanced Bionics is releasing the software used to program HiRes (called SoundWave') in a controlled fashion. The company is working with each cochlear implant center individually to ensure that they are fully trained and certified on the new fast and efficient programming methodology. Certification of cochlear implant centers started in June and is progressing rapidly.
Advanced Bionics is the leading innovator of cochlear implants with more U.S. technology patents than all other cochlear implant manufacturers combined. Imagine the Possibilities'.